Sponsors (2)
The bill significantly expands and speeds federally supported marijuana research—providing new grant money, agency coordination, and participant protections—while increasing federal spending and leaving legal, implementation, equity, oversight, and international-diplomacy risks that could limit or complicate its benefits.
Researchers at U.S. colleges and universities receive dedicated grant funding ($15M/year for medical/public-health research + $15M/year for cultivation research for FY2026–2030), increasing research capacity and potential patient and agricultural benefits.
DEA and federal agencies will reduce administrative barriers for academic research (new DEA priority factor for universities, a centralized outreach office, application amendment technology, and improved NIH/FDA/DEA coordination), speeding registrations and increasing research output.
Students and covered researchers are protected from losing Federal student aid or other federal funding and from immigration consequences when participating in approved marijuana research, lowering personal risk to participants.
The bill increases federal spending and administrative costs (grant budgets plus creating/operating a new DEA office and related technology), imposing new costs on taxpayers and potentially increasing deficits if not offset.
Researchers and institutions still face federal-state legal tension and possible federal criminal exposure because marijuana remains federally controlled, leaving implementation and legal risk uneven across jurisdictions.
Program eligibility and priorities (limiting awards to institutions of higher education and favoring institutions in States/tribal lands where marijuana is legal) can exclude qualified nonacademic researchers, private firms, and institutions in prohibition states, reducing nationwide participation.
Based on analysis of 8 sections of legislative text.
Speeds DEA approvals, creates DEA university outreach, and funds NIH and USDA competitive grants to expand marijuana research at colleges (authorizes $15M/year each, FY2026–2030).
Authorizes federal support and administrative reforms to expand marijuana research at U.S. institutions of higher education. It directs DEA, NIH, and USDA to speed and simplify registration, create university outreach, and run competitive grant programs for medical, public health, and agricultural marijuana research, with $15 million annually at NIH (2026–2030) and $15 million annually at USDA (2026–2030). Also creates procedural protections for participating students, researchers, and institutions (including protection of federal student aid and immigration consequences), allows institutions in States or tribal lands that legalize marijuana to obtain cannabis from State/tribal regulators or law enforcement for research (but not to administer law-enforcement-supplied marijuana to people), and clarifies that a UN narcotics treaty provision should not be read to restrict lawful U.S. research under the Controlled Substances Act and this Act.
Official title: To streamline the process for institutions of higher education to research marijuana.
Introduced April 20, 2026 by Alice Costandina Titus · Last progress April 20, 2026